Inhibrx Biosciences, Inc. INBX Business Segments — Equipment, depreciation, and facility
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept inbx:ResearchAndDevelopmentExpenseEquipmentDepreciationAndFacility.
The official record: Inhibrx Biosciences, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s business segments — equipment, depreciation, and facility.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s business segments — equipment, depreciation, and facility?
- Inhibrx Biosciences, Inc. (INBX) reported business segments — equipment, depreciation, and facility of $2.56M in Q4 2025.
- How has Inhibrx Biosciences, Inc.'s business segments — equipment, depreciation, and facility changed year-over-year?
- Inhibrx Biosciences, Inc.'s business segments — equipment, depreciation, and facility increased by 5.5% year-over-year, from $2.42M to $2.56M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s business segments — equipment, depreciation, and facility?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s business segments — equipment, depreciation, and facility has grown at a 17.6% compound annual growth rate (CAGR), from $7.4M to $10.23M.
- What does business segments — equipment, depreciation, and facility mean?
- Includes the depreciation of laboratory equipment and the costs associated with maintaining facilities used by the reportable segment. It represents the fixed overhead required to sustain the physical infrastructure necessary for research and development.